Ching‐Yao Yang

Programmed cell death-ligand 1 expression in surgically resected stage I pulmonary adenocarcinoma and its correlation with driver mutations and clinical outcomes

Ching‐Yao Yang, Mong‐Wei Lin, Yih‐Leong Chang et al. · European Journal of Cancer · 2014 · 287 citations

Medicine, Genetics, Oncology +16

Programmed cell death-ligand 1 expression is associated with a favourable immune microenvironment and better overall survival in stage I pulmonary squamous cell carcinoma

Ching‐Yao Yang, Mong‐Wei Lin, Yih‐Leong Chang et al. · European Journal of Cancer · 2016 · 124 citations

Medicine, Immunology, Oncology +14

High co-expression of PD-L1 and HIF-1α correlates with tumour necrosis in pulmonary pleomorphic carcinoma

Yih‐Leong Chang, Ching‐Yao Yang, Mong‐Wei Lin et al. · European Journal of Cancer · 2016 · 118 citations

Medicine, Oncology, Pathology +17

PD-L1 is highly expressed in lung lymphoepithelioma-like carcinoma: A potential rationale for immunotherapy

Yih‐Leong Chang, Ching‐Yao Yang, Mong‐Wei Lin et al. · Lung Cancer · 2015 · 98 citations

Medicine, Cancer Biology, Oncology +14

Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors

Ching‐Yao Yang, Wei‐Yu Liao, Chao‐Chi Ho et al. · European Journal of Cancer · 2019 · 91 citations

Medicine, Immunology, Oncology +17